slides · global inventory
Paragraph
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 118,471
Current window 89,401-89,430
Pages 3,950
Rows per page 30
Component
89,401-89,430 of 118,471
22
Includes bioluminescence imaging time-series and Kaplan-Meier survival curve.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · Traction1 hit
23
Kaplan-Meier survival plots are standard for preclinical efficacy demonstration.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · Traction1 hit
24
The slide outlines a standard 3+3 dose escalation clinical trial design.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · Traction1 hit
25
The slide details the transition from healthy donor leukapheresis through genetic modification (using AAV, Cas9, and chRDNA) to final cryopreservation and treatment.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · Traction1 hit
34
The slide uses a checkmark vs X comparison table to establish competitive advantage.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · Traction1 hit
35
The chart is a Kaplan-Meier survival plot. The p-value < 0.0001 indicates statistical significance.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · Traction1 hit
37
The slide features a stylized illustration of a cell, likely an NK cell, interacting with other cells.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank 1 hit
44
Caribou Biosciences | IPO Presentation Deck | 44 slidesCaribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank 1 hit
01
Central Pacific Financial | Results Presentation Deck | 13 slidesCentral Pacific Financial | Results Presentation Deck | 13 slides · Central Pacific Financial
Conference presentation Investor relations 1 hit
13
The table provides a bridge between GAAP reported figures and adjusted figures by removing PPP-related impacts.Central Pacific Financial | Results Presentation Deck | 13 slides · Central Pacific Financial
Conference presentation Investor relations 1 hit
01
Crocs | Investor Presentation Deck | 30 slidesCrocs | Investor Presentation Deck | 30 slides · Crocs
Conference presentation Investor relations 1 hit
06
Crocs | Investor Presentation Deck | 30 slidesCrocs | Investor Presentation Deck | 30 slides · Crocs
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
10
The slide uses a visual collage approach to demonstrate brand engagement strategies.Crocs | Investor Presentation Deck | 30 slides · Crocs
Conference presentation Investor relations 1 hit
11
The slide uses visual examples of product collaborations to demonstrate brand strategy.Crocs | Investor Presentation Deck | 30 slides · Crocs
Conference presentation Investor relations 1 hit
24
Includes footnotes explaining adjustments for new distribution centers and COVID-19 inventory write-offs.Crocs | Investor Presentation Deck | 30 slides · Crocs
Conference presentation Investor relations 1 hit
27
Includes footnotes explaining non-GAAP adjustments and the 2020 intra-entity IP transfer.Crocs | Investor Presentation Deck | 30 slides · Crocs
Conference presentation Investor relations 1 hit
01
Erasca | IPO Presentation Deck | 46 slidesErasca | IPO Presentation Deck | 46 slides · Erasca
Pitch deck Investment bank 1 hit
04
The slide combines mission statement, company history, pipeline milestones, and investor logos.Erasca | IPO Presentation Deck | 46 slides · Erasca
Pitch deck Investment bank 1 hit
07
The chart uses a waterfall structure to show the cumulative total of patient lives affected across different cancer types and regions.Erasca | IPO Presentation Deck | 46 slides · Erasca
Pitch deck Investment bank Beat · ProblemLoop · Pattern Hunter1 hit
08
The table uses color coding to distinguish between market types. The 'Red ocean' cells are highlighted in red, while the rest are blue. The bottom rows show geographic totals.Erasca | IPO Presentation Deck | 46 slides · Erasca
Pitch deck Investment bank Beat · ProblemLoop · Pattern Hunter1 hit
10
The slide uses a Gantt-style chart to represent clinical trial progress across multiple programs.Erasca | IPO Presentation Deck | 46 slides · Erasca
Pitch deck Investment bank Beat · Solution1 hit
15
The chart shows a logarithmic scale for IC50 (nM) across different cell lines grouped by mutation status (BRAF, HRAS, KRAS, NRAS, wildtype).Erasca | IPO Presentation Deck | 46 slides · Erasca
Pitch deck Investment bank 1 hit
16
Erasca | IPO Presentation Deck | 46 slidesErasca | IPO Presentation Deck | 46 slides · Erasca
Pitch deck Investment bank 1 hit
20
The slide demonstrates efficacy in two distinct models (HCC827/ER1 and NCI-H820).Erasca | IPO Presentation Deck | 46 slides · Erasca
Pitch deck Investment bank Beat · Traction1 hit
23
The chart uses color to represent dosage and symbols to represent clinical response (Partial Response, Stable Disease, Progressive Disease).Erasca | IPO Presentation Deck | 46 slides · Erasca
Pitch deck Investment bank Beat · Traction1 hit
25
The slide highlights that QW dosing is better tolerated, specifically noting less rash and manageable side effects compared to QD dosing.Erasca | IPO Presentation Deck | 46 slides · Erasca
Pitch deck Investment bank Beat · Traction1 hit
27
The slide uses a line chart to show drug concentration over time and a table to summarize key PK/PD metrics (Cmax, Cmin, T>IC90, T<IC50).Erasca | IPO Presentation Deck | 46 slides · Erasca
Pitch deck Investment bank 1 hit
29
The slide uses a table to contrast the target (SHP2) against a panel of off-target phosphatases.Erasca | IPO Presentation Deck | 46 slides · Erasca
Pitch deck Investment bank 1 hit
40
TGI = Tumor Growth Inhibition. CDX = Cell line-derived xenograft. MIA PaCa-2 is a human pancreatic cancer cell line.Erasca | IPO Presentation Deck | 46 slides · Erasca
Pitch deck Investment bank 1 hit
15
The chart highlights the impact of the 2020 pandemic and the subsequent recovery, supporting the claim of non-discretionary demand.European Wax Center | IPO Presentation Deck | 34 slides · European Wax Center
Pitch deck Investment bank 1 hit